ES2686114T3 - El ácido hialurónico y su uso para el tratamiento de la insuficiencia venosa y las venas varicosas - Google Patents

El ácido hialurónico y su uso para el tratamiento de la insuficiencia venosa y las venas varicosas Download PDF

Info

Publication number
ES2686114T3
ES2686114T3 ES11194672.9T ES11194672T ES2686114T3 ES 2686114 T3 ES2686114 T3 ES 2686114T3 ES 11194672 T ES11194672 T ES 11194672T ES 2686114 T3 ES2686114 T3 ES 2686114T3
Authority
ES
Spain
Prior art keywords
optionally
needle
catheter
diameter
tip
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11194672.9T
Other languages
English (en)
Inventor
Johann Christof Ragg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angioclinic AG
Original Assignee
Angioclinic AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angioclinic AG filed Critical Angioclinic AG
Application granted granted Critical
Publication of ES2686114T3 publication Critical patent/ES2686114T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/06—Body-piercing guide needles or the like
    • A61M25/0606—"Over-the-needle" catheter assemblies, e.g. I.V. catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00778—Operations on blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00778—Operations on blood vessels
    • A61B2017/00783—Valvuloplasty
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
    • A61M2025/0042—Microcatheters, cannula or the like having outside diameters around 1 mm or less
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/06—Body-piercing guide needles or the like
    • A61M25/0693—Flashback chambers

Abstract

Un sistema de catéter que comprende cánulas para punción vascular con una punta de doble o triple corte, que comprende: (i) una parte exterior (elemento no cortante), que es un elemento tubular de material metálico o plástico que tiene un diámetro exterior de 0,9 a 1,2 mm y un diámetro interior de 0,8 a 1,1 mm, y es ligeramente flexible, (a) donde, opcionalmente, la zona de la punta es de sección decreciente para facilitar la introducción, (b) donde, opcionalmente, los bordes son redondeados para permitir un avance no traumático, (c) que, opcionalmente, tiene un conector Luer Lock; (ii) una aguja hueca que es flexible y se puede doblar, (a) que, opcionalmente, tiene una cámara de reflujo transparente, (b) donde el diámetro de la aguja es inferior al diámetro del catéter; donde (iii) la aguja y el catéter están conectados mediante una traba temporal con el fin de garantizar que la punta de la aguja permanezca fija en la posición adecuada fuera del catéter durante la punción de la piel y la introducción hacia la región diana.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10

Claims (1)

  1. imagen1
ES11194672.9T 2011-12-20 2011-12-20 El ácido hialurónico y su uso para el tratamiento de la insuficiencia venosa y las venas varicosas Active ES2686114T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11194672.9A EP2606828B1 (en) 2011-12-20 2011-12-20 Hyaluronic acid and its use for treating venous insufficiency and varicose veins

Publications (1)

Publication Number Publication Date
ES2686114T3 true ES2686114T3 (es) 2018-10-16

Family

ID=47603542

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11194672.9T Active ES2686114T3 (es) 2011-12-20 2011-12-20 El ácido hialurónico y su uso para el tratamiento de la insuficiencia venosa y las venas varicosas

Country Status (7)

Country Link
US (2) US9730887B2 (es)
EP (3) EP2606828B1 (es)
CN (1) CN104010578B (es)
ES (1) ES2686114T3 (es)
IN (1) IN2014MN01449A (es)
RU (1) RU2674478C2 (es)
WO (1) WO2013092860A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9421198B2 (en) 2013-07-30 2016-08-23 Teoxane Composition comprising hyaluronic acid and mepivacaine
JP6715854B2 (ja) * 2014-11-14 2020-07-01 ディーアールジョージアリー ピーティーイー．リミテッド 医療器具
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
CN107335114B (zh) * 2016-04-29 2020-06-05 黄翔 针头结构
TR201710921A2 (tr) 2017-07-26 2019-02-21 Rd Global Arastirma Gelistirme Saglik Ilac Insaat Yatirimlari Sanayi Ve Ticaret Anonim Sirketi İnternal kompresyon tedavi̇si̇ (ict)
WO2019121694A1 (en) * 2017-12-22 2019-06-27 Nestlé Skin Health Sa Injectable compositions of cross-linked hyaluronic acid and bupivacaine, and uses thereof
KR102295832B1 (ko) * 2019-07-18 2021-09-01 한국기계연구원 혈관 주입 여부의 확인이 가능한 캐뉼라

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
EP1263325B1 (en) * 2000-03-06 2009-07-01 Boston Scientific Limited Embolic agents visible under ultrasound
CN1774272A (zh) * 2000-12-07 2006-05-17 株式会社日本组织工程 组织再生用基材、移植用材料及其制备方法
JP2003119147A (ja) * 2001-10-10 2003-04-23 Raku:Kk ヒアルロン酸化合物の水溶液組成物
US7820194B2 (en) * 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
EP1386633A1 (en) * 2002-08-02 2004-02-04 Sergio Restelli Safety catheter
US7125396B2 (en) * 2002-12-30 2006-10-24 Cardinal Health 303, Inc. Safety catheter system and method
WO2004098669A1 (en) * 2003-05-05 2004-11-18 Ben-Gurion University Of The Negev Research And Development Authority Injectable cross-linked polymeric preparations and uses thereof
US20040267204A1 (en) * 2003-06-26 2004-12-30 Brustowicz Robert M. On-demand needle retaining and locking mechanism for use in intravenous catheter assemblies
AU2003903990A0 (en) * 2003-07-31 2003-08-14 Medigard Pty Ltd Cannula/catheter introducer
EP1684666A4 (en) * 2003-10-14 2010-04-07 James C Peacock Iii ANEURYSMA TREATMENT SYSTEM AND METHOD
US20070224278A1 (en) * 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
RU2367464C2 (ru) * 2004-02-19 2009-09-20 Берингер Ингельхайм Интернациональ Гмбх Состав для лечения хронических венозных недостаточностей, содержащий водный экстракт листьев красного винограда и противовоспалительное средство
RU2272634C1 (ru) * 2004-07-07 2006-03-27 Общество с ограниченной ответственностью "Аполло инвестментс" Способ омоложения кожи
US7402320B2 (en) * 2004-08-31 2008-07-22 Vnus Medical Technologies, Inc. Apparatus, material compositions, and methods for permanent occlusion of a hollow anatomical structure
US7387604B2 (en) * 2004-11-03 2008-06-17 Cook Incorporated Methods for treating valve-associated regions of vascular vessels
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US20070031467A1 (en) * 2005-08-04 2007-02-08 Abrahams John M Composition and method for vascular embolization
KR100803576B1 (ko) * 2006-06-14 2008-02-15 주식회사 인피트론 지방줄기세포 및 지방세포를 포함한 이식용 조성물
US20080050436A1 (en) * 2006-08-25 2008-02-28 Chu Jack F Methods and compounds for obliteration of vessels
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
US20120071437A1 (en) * 2007-07-30 2012-03-22 Allergan, Inc. Tunable crosslinked polysaccharide compositions
WO2009034579A1 (en) * 2007-09-06 2009-03-19 Manoj Kumar Maan Safety i. v. cannula
US8450475B2 (en) * 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
US20100104654A1 (en) * 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
EP2990051B1 (en) 2009-04-10 2016-10-26 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (mmp-1)
US9180089B2 (en) * 2009-09-23 2015-11-10 Glenpharma Ab Compositions and methods for inducing or enhancing connective tissue repair
US8283463B2 (en) * 2010-02-09 2012-10-09 Bausch & Lomb Incorporated Sterile hyaluronic acid solutions
US9005605B2 (en) * 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods

Also Published As

Publication number Publication date
CN104010578A (zh) 2014-08-27
US9730887B2 (en) 2017-08-15
EP3868386A1 (en) 2021-08-25
CN104010578B (zh) 2019-01-15
EP2793710A2 (en) 2014-10-29
WO2013092860A3 (en) 2013-12-05
EP2606828A1 (en) 2013-06-26
WO2013092860A2 (en) 2013-06-27
EP2606828B1 (en) 2018-04-11
EP3868386B1 (en) 2024-03-06
RU2674478C2 (ru) 2018-12-11
US20140378411A1 (en) 2014-12-25
US20160213607A1 (en) 2016-07-28
RU2014124987A (ru) 2016-02-10
IN2014MN01449A (es) 2015-04-03

Similar Documents

Publication Publication Date Title
ES2686114T3 (es) El ácido hialurónico y su uso para el tratamiento de la insuficiencia venosa y las venas varicosas
ES2560469T3 (es) Dispositivos y métodos para la dilatación transnasal y riego de los senos paranasales
ES2627353T3 (es) Flujo de elementos para uso con agujas espinales flexibles, ensamblajes de aguja y métodos para su fabricación
ES2478292T3 (es) Unidad de tambor con aguja oculta para lápiz de administración de fármaco
EP3821818A3 (en) Catheter device for transmitting and reflecting light
CO6640261A2 (es) Dispositivo de seguridad de aguja para dispositivos médicos
CA2902713C (en) Method and apparatus for drug delivery to a target site
WO2015179351A3 (en) Heart assist systems and methods
RU2015118459A (ru) Медицинское устройство, содержащее криволинейную иглу
CO6620007A2 (es) Aparato de catéter
BR112015021446A2 (pt) métodos cirúrgicos empregando composições de peptídeo amfifílico purificado
ES2678768T3 (es) Instrumento quirúrgico
EA201691295A1 (ru) Медицинское устройство, содержащее электрод и источник света
JP2016537079A5 (es)
RU2011143737A (ru) Стержень для абляционного катетера с баллоном
AR113835A1 (es) Análogos y pepticuerpos de glp-2 para la administración antes, durante o después de la cirugía
CR20150564A (es) Punta de material reducido para catéter y método de formación de la misma
BR112017002879A2 (pt) balões revestidos e conjuntos de balões revestidos e métodos relacionados de uso e fabricação
ECSP13013104A (es) Manguito protector de punta.
CR20150461A (es) Catéter de balón
CO6741196A2 (es) Aparato de catéter intravenoso
BR112017022313A2 (pt) agulha oca para um instrumento cirúrgico oftálmico
MX2016015116A (es) Manguito para cateter sobre aguja.
WO2014145105A3 (en) Delivery catheter
RU2012111818A (ru) Медицинская хирургическая игла